Tianjin Medical University General Hospital
Clinical trials sponsored by Tianjin Medical University General Hospital, explained in plain language.
-
New pain drug may stop chronic pain after lung surgery
Disease control Not yet recruitingThis study tests if a painkiller called oliceridine can prevent long-term pain after lung surgery better than the standard drug. About 320 adults having keyhole lung surgery will receive either oliceridine or sufentanil during and after the operation. Researchers will check pain …
Phase: PHASE4 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated May 17, 2026 08:33 UTC
-
Could a simple saline drip boost stroke recovery? new trial aims to find out
Disease control Not yet recruitingThis study tests whether giving a large amount of IV saline (about 2-2.5 liters) right after clot-busting treatment helps people with acute ischemic stroke recover better. About 752 adults aged 18-80 who had a stroke and received thrombolysis will be randomly assigned to get eith…
Phase: PHASE3 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated May 17, 2026 08:19 UTC
-
Immune cell boost may overcome lung cancer drug resistance
Disease control Not yet recruitingThis early-stage study tests whether adding a patient's own immune cells (TILs) to a targeted therapy (EGFR-TKI) is safe for people with advanced lung cancer that no longer responds to standard targeted drugs. About 50 adults aged 18-75 with EGFR-mutant non-small cell lung cancer…
Phase: EARLY_PHASE1 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Immune cell therapy shows promise for early lung cancer in new safety trial
Disease control Not yet recruitingThis early-stage study tests whether a therapy using a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), is safe for people with multiple early-stage non-small cell lung cancer. Researchers will enroll 50 participants and monitor side effects. The goal is …
Phase: EARLY_PHASE1 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Itching breakthrough: esketamine shot may soothe pregnancy cholestasis
Symptom relief Not yet recruitingThis study tests whether a single injection of esketamine given during a C-section can lessen severe itching in pregnant women with intrahepatic cholestasis of pregnancy. About 160 women with moderate to severe itching will receive either esketamine or a placebo, and their itchin…
Phase: NA • Sponsor: Tianjin Medical University General Hospital • Aim: Symptom relief
Last updated May 04, 2026 16:22 UTC